S. Muthian
发表
CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain.
J. Masferrer,
M. Graneto,
G. Anderson,
2009,
European journal of pharmacology.
D. Deutsch,
C. Hillard,
K. Tsou,
1998,
Neuroscience Letters.
S. Mnich,
R. Hiebsch,
S. Muthian,
2010
.
W. Campbell,
K. Nithipatikom,
C. Hillard,
2000,
The Journal of pharmacology and experimental therapeutics.
W. Campbell,
K. Nithipatikom,
C. Hillard,
2000
.
W. Campbell,
C. Hillard,
W. Edgemond,
1998,
The Journal of pharmacology and experimental therapeutics.
C. Hillard,
Sachin Patel,
A. Greene,
2002,
Neuroscience Letters.
C. Hillard,
C. Kearn,
S. Muthian,
1999
.
S. Mnich,
R. Hiebsch,
S. Muthian,
2010,
Journal of Pharmacology and Experimental Therapeutics.
D. J. Rademacher,
G. Gross,
C. J. Hillard,
2004,
Neuroscience.
W. Campbell,
C. Hillard,
W. Edgemond,
1998
.